Accessibility settings

This paper is in the following e-collection/theme issue:

Ethics, Privacy, and Legal Issues (853) Artificial Intelligence (5110) Innovations in Clinical Trials and Research Data Management (225) Health Information Governance (134) Responsible Health AI (275) Academic Professionalism and Ethical Practices (14)

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/94504, first published .
Digital brain with circuits, data flow, and informed consent document

Informed Consent Disclosures and Minimum Requirements in AI Clinical Trials: Cross-Sectional Analysis

Informed Consent Disclosures and Minimum Requirements in AI Clinical Trials: Cross-Sectional Analysis

Authors of this article:

Hankun Su1, 2 Author Orcid Image ;   Fen Xiao1, 2 Author Orcid Image ;   Hoksan Chau1, 2 Author Orcid Image ;   Yuqian Tong1, 2 Author Orcid Image ;   Siyi Han1, 2 Author Orcid Image ;   Xinyu Cheng1, 2 Author Orcid Image ;   Zhilin Che1, 2 Author Orcid Image ;   Liye Sun1, 2 Author Orcid Image ;   Yuemeng Yang1, 2 Author Orcid Image ;   Jing Zhao1, 2 Author Orcid Image ;   Yanping Li1, 2 Author Orcid Image ;   Hui Li1, 2 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics Author Video

Journals

  1. Runde A, Fahey J, Pelit W, Ortiz C, Koo S, Jordan L, Chrulski K, Kleberg J, Buckner H, Brown N, Shahid R. Of Silicon and Cells: Ethical and Safety Concerns Regarding Artificial Intelligence Usage in the Biomedical Sciences—A Narrative Review. Life 2026;16(11):1785 View